Recently, The New England Journal of Medicine published the results of the EVERDAC trial, which compared a strategy of noninvasive monitoring with early arterial catheterization in patients with shock. The study demonstrated that, in the intensive care setting, an initial noninvasive strategy was not inferior to early arterial catheter insertion with respect to 28-day mortality.1 This finding is not entirely surprising, as to date no invasive hemodynamic monitoring system—including the pulmonary artery catheter or devices based on transpulmonary thermodilution or pulse-wave analysis—has consistently demonstrated a mortality reduction, although such tools may help optimize resuscitation and improve intermediate outcomes.2

In recent years, critical care medicine has moved toward an increasingly individualized model, in which shock resuscitation is guided by growing integration of physiological variables and advanced monitoring. Pulse-wave analysis, dynamic preload assessment, and peripheral perfusion indices exemplify our efforts to better understand the physiology of the critically ill patient and tailor interventions to meet individual hemodynamic profiles.3

The EVERDAC trial, along with other recent studies such as the ANDROMEDA-SHOCK-2, which compared lactate-guided and peripheral perfusion–guided strategies, invites reflection on a fundamental question: to what extent does technological complexity truly improve clinical outcomes? Despite methodological differences, both studies converge on a shared message: in many cases, simple tools, when applied with physiological reasoning and clinical rigor, may be sufficient.1,4

This concept is consistent with the systematic review on the shock index in septic shock published by Diaztagle Fernández et al. in MEDICINA INTENSIVA, which highlights the usefulness of simple clinical parameters for risk stratification and guidance of early resuscitation without the need for invasive devices.5 Similarly, the article by Clau Terré et al. on new ultrasound techniques underscores the growing role of bedside ultrasonography as an essential component of multimodal monitoring, particularly as a dynamic and noninvasive tool for evaluating the critically ill patient.6 Both works reinforce the notion that early shock management can be effectively supported by well-integrated noninvasive methods, fully consistent with the strategy assessed in EVERDAC.

Therefore, the key may not lie in opposing technology and simplicity, but in integrating them. Advanced monitoring should coexist with, and complement, the intensivist’s clinical assessment rather than replace it.2,3 Clinical experience and judgment remain indispensable for contextualizing data and determining which intervention is truly necessary at each moment.

Ultimately, personalized medicine is not defined by the number of parameters obtained, but by the ability to interpret them within context and apply them to guide optimal therapy for each patient. Monitoring—whether invasive or noninvasive—must be understood as a tool in service of physiological reasoning, not as an end in itself. Only through this integration of technology, physiology, and clinical judgment can we move toward truly patient-centered care for the critically ill.